Accuray Unveils Financial Results and Strategic Moves in Fiscal 2026 Quarter One Accuray reports its first quarter financial results for fiscal 2026, announcing leadership changes, restructuring plans, and product innovations.

Accuray Unveils Financial Results and Strategic Moves in Fiscal 2026 Quarter One #USA #Accuray #CyberKnife #Madison,_Wisconsin #Radixact

Accuray Expands Chinese Product Portfolio with New Approvals for Advanced Radiation Therapy Systems Accuray has gained approval for its Radixact SynC and CyberKnife S7 Systems in China, significantly enhancing treatment options for cancer patients.

Accuray Expands Chinese Product Portfolio with New Approvals for Advanced Radiation Therapy Systems #China #Wisconsin #Accuray #CyberKnife #Radixact